Back to Search Start Over

Treatment with monoclonal antibodies against clostridium difficile toxins

Authors :
Lowy, Israel
Molrine, Deborah C.
Leav, Brett A.
Blair, Barbra M.
Baxter, Roger
Gerding, Dale N.
Nichol, Geoffrey
Thomas, William D. Jr.
Leney, Mark
Sloan, Susan
Hay, Catherine A.
Ambrosino, Donna M.
Source :
The New England Journal of Medicine. Jan 21, 2010, Vol. 362 Issue 3, p197, 9 p.
Publication Year :
2010

Abstract

A study was conducted to evaluate the efficacy and safety of CDA1 plus CDB1 monoclonal antibodies in preventing the recurrence of clostridium difficile infections. Results indicated that the addition of such monoclonal antibodies to antibiotic agents significantly reduced the recurrence of such infections.

Subjects

Subjects :
Monoclonal antibodies -- Usage
Monoclonal antibodies -- Health aspects
Monoclonal antibodies -- Research
Clostridium difficile -- Prevention

Details

Language :
English
ISSN :
00284793
Volume :
362
Issue :
3
Database :
Gale General OneFile
Journal :
The New England Journal of Medicine
Publication Type :
Academic Journal
Accession number :
edsgcl.218489422

Tools

Authors Abstract Subjects Details